Surgeon practices regarding infection prevention for growth friendly spinal procedures by Glotzbecker, Michael P. et al.
 
Surgeon practices regarding infection prevention for growth
friendly spinal procedures
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Glotzbecker, Michael P., Sumeet Garg, Behrooz A. Akbarnia,
Michael Vitale, Tricia St Hillaire, and Ajeya Joshi. 2014.
“Surgeon practices regarding infection prevention for growth
friendly spinal procedures.” Journal of Children's Orthopaedics 8
(3): 245-250. doi:10.1007/s11832-014-0584-1.
http://dx.doi.org/10.1007/s11832-014-0584-1.
Published Version doi:10.1007/s11832-014-0584-1
Accessed February 16, 2015 9:09:14 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12785917
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAORIGINAL CLINICAL ARTICLE
Surgeon practices regarding infection prevention for growth
friendly spinal procedures
Michael P. Glotzbecker • Sumeet Garg •
Behrooz A. Akbarnia • Michael Vitale •
Tricia St Hillaire • Ajeya Joshi
Received: 6 February 2014/Accepted: 1 April 2014/Published online: 18 April 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Purpose The rate of infection in patients having growth
sparing surgery for early onset scoliosis has been reported
up to 25 % during the course of treatment. A recent study
demonstrated signiﬁcant variability in the approach to
infection prevention in adolescent and neuromuscular
scoliosis. The purpose of this study is to conduct a similar
survey in order to understand approaches used by experi-
enced pediatric spinal surgeons with regard to infection
prevention in growth friendly spinal procedures.
Materials and methods After preliminary internal testing
of a survey by the authors, a ﬁnal 21-question survey was
created and approved by the authors and electronically
distributed to all members of the Chest Wall Spinal
Deformity Study Group and the Growing Spine Study
Group (n = 57). A total of 40 responses were obtained
(70 %).
Results Signiﬁcant variability in practice was demon-
strated across the majority of the questions answered.
Several of the questions demonstrated relative equipoise
between practices, including preoperative MRSA screen-
ing, preoperative chlorhexidine baths, postoperative anti-
biotic duration after insertion, use of topical antibiotics, use
of drains, use of IV gram negative coverage or vancomy-
cin, and skin preparation.
Conclusion Other studies have demonstrated that vari-
ability in practice may have a negative impact on clinical
outcomes, so one could postulate that steps that can reduce
variability in the current population may help improve
outcomes in this population. Areas of clinical equipoise can
be used to help design and direct multicenter studies with
an ultimate goal of reducing infections in this population.
Level of evidence Level V.
Keywords Spinal infection  Growth friendly surgery 
Early onset scoliosis  Infection prevention  Infection
reduction
Introduction
The consequences of a postoperative spinal infection
include signiﬁcant direct and indirect costs [1]. The rate of
infection in patients after growth sparing surgery for early
onset scoliosis (EOS) has been reported in up to 25 % of
patients during the course of treatment (unpublished data)
[2–4]. Surgical site infections are associated with
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DOI 10.1007/s11832-014-0584-1prolonged hospital stays and IV antibiotic regimens, and
frequently require multiple reoperations for debridements
and implant removal [1, 5, 6].
As demonstrated by a recent systematic review of the
literature, there is a lack of well-designed trials and evi-
dence in the pediatric literature to help guide infection
prevention strategies after pediatric deformity surgery in
the adolescent and neuromuscular populations [7]. With a
lack of good evidence, attempts to adopt best practice are
unfortunately often dictated by personal experience. This
leads to signiﬁcant variability in practice patterns in the
approach to infection prevention in deformity surgery [8].
Understanding current surgical practices, as well as the
current literature, are initial steps required to reduce vari-
ability of practice through the development and adoption of
best evidence guidelines [9]. Such guidelines can improve
clinical outcomes and reduce healthcare costs [10–12].
While a recent survey demonstrated signiﬁcant variability
in adolescent idiopathic and neuromuscular surgery [8], the
growing spine population is unique with regard to under-
lying diagnosis, risk factors, and surgical techniques. The
purpose of this study is to understand approaches used by
experienced pediatric spinal surgeons with regard to
infection prevention after growth friendly spinal
procedures.
Materials and methods
After creation and preliminary internal testing of a survey
by the authors, a ﬁnal 21-question survey was approved by
the authors and electronically distributed to all 57 members
of the Chest Wall and Spinal Deformity Study Group and
the Growing Spine Study Group (n = 57). Questions
focused on current practices involving infection prevention
when using growth friendly implants, and included practice
patterns during initial insertion as well as after lengthening
procedures. The questions were developed through dis-
cussion by the authors, and were derived from techniques
currently commonly used in early onset and adolescent
populations [7–9]. The basis of the current survey was a
similar survey considering infection prevention practices in
high risk (neuromuscular) populations [8]. While many
questions were similar in the two surveys, different ques-
tions were required for this survey as the population and
the surgeries used in this population are associated with
unique issues. Each question was in multiple choice format
and was followed by 2–8 possible responses. When
appropriate, an open ended response ‘‘other (please spec-
ify)’’ was included to accommodate additional comments
or choices that were not listed as options (Supplementary
Appendix 1). It took approximately 5 min to complete, and
40 responses were obtained (70 %).
Source of funding
No external funding source was required for the current
study. No funding was received for this work from any of
the following organizations: National Institutes of Health
(NIH); Welcome Trust; Howard Hughes Medical Institute
(HHMI).
Statistical methods
No statistical analysis was needed for the current study.
Results (Tables 1, 2)
Insertion Procedures
Of the respondents, 46.1 % of surgeons use chlorhexidine
baths at home preoperatively for insertions, 42.5 % obtain
preoperative laboratories (such as albumin, prealbumin,
TWBC, TLC, serum transferrin) to stratify for infection,
and 30.8 % obtain MRSA swabs to guide preoperative
antibiotic choice.
When choosing preoperative prophylactic antibiotics,
74.4 % use intravenous (IV) cephalosporin, 17.9 % use IV
vancomycin or cefazolin based on the results of the pre-
operative MRSA nasal swab culture, 5.1 % use IV van-
comycin, 5.1 % use clindamycin, and 12.8 % use gram
negative coverage (gentamycin). Other (10.2 %) responses
included using gram negative coverage for incontinent or
high-risk patients. Of surgeons using antibiotics, 64.1 %
use them for 24 h or less, while 33.3 % continue prophy-
lactic antibiotics for [24 h, and 2.6 % use only a single
preoperative dose.
Skin preparation used for insertion procedures (surgeon
allowed to choose more than one) included betadine
(povidone iodine) in 23.1 % of patients, duraprep
 (iodine
povacrylex and isopropyl alcohol) in 23.1 %, chloraprep

(chlorhexidine gluconate) in 61.5 %, alcohol in 38.5 %,
and other modalities in 15.4 %. Other responses included
using scrub or soap prior to other prep solutions (Fig. 1).
Regarding incisions, 57.9 % of surgeons make a separate
fascial incision from the skin incision for both VEPTR

and growing rods, 28.9 % do it for VEPTR
 procedures
only, and 2.6 % do it for growing rods procedures only;
however, 10.5 % do not make a separate fascial incision
from the skin incision. Trafﬁc is limited in the operating
room during the procedure by 63.2 % of surgeons
surveyed.
For irrigating the wounds prior to closure, 66.7 % of
surgeons use a bulb syringe, 28.2 % use pulse lavage, and
5.1 % use cysto tubing. For an insertion procedure, 74.4 %
use saline, 15.4 % use bacitracin and saline, 17.9 % use
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123dilute betadine, and 7.7 % use other ﬂuids such as kefzol or
triple antibiotics for their intraoperative irrigant. For an
insertion procedure, 41 % use intraoperative topical van-
comycin in the wound/bone graft, while 48 % do not use
intraoperative antibiotics. Drains are used by 41.1 % of
surgeons for insertion procedures. For a postoperative
dressing, 28.2 % use moist nonadherent dressing (adaptic,
xeroform, etc.), 20.5 % use standard seal tape (silk, paper,
metapore, etc.), 59 % use impervious seal dressing, 25.6 %
use padding, and 25.6 % use other dressings such as silver
impregnated dressings, dermabond, or mepilex.
Lengthening procedure
41 % of surgeons use chlorhexidine baths at home prior to
a lengthening procedure. Five percent of surgeons obtain
preoperative labs prior to a lengthening procedure. 74.4 %
use IV cephalosporin, 2.6 % use IV vancomycin, 5.1 % use
clindamycin, and 2.6 % use gram negative coverage
(gentamycin) as standard preoperative antibiotic prior to a
lengthening procedure. 15.4 % use IV vancomycin or
cefazolin based on a preoperative MRSA culture. Other
responses included using gram negative coverage for
incontinent or high risk patients. 47 % do not give post-
operative antibiotics after a lengthening procedure, 47.4 %
continue them for 24 h or less, 2.6 % continue IV antibi-
otics for[24 h, and 2.6 % use oral antibiotics for[24 h.
Skin preparation used for lengthening procedure include
betadine (23.7 %), duraprep
 (23.7 %), chloraprep

(60.5 %), alcohol (36.8 %), and other (15.8 %). Other
responses included using scrub or soap prior to other prep
solutions. For a lengthening procedure, 84.2 % of surgeons
Table 1 Summary of survey results to questions asked including
most common and other methods used
Intervention Most commonly
used (% used)
Other methods used (% used)
Preoperative prophylactic antibiotics
Insertion IV cephalosporin
(74.4)
IV vancomycin vs. cephalosporin
based on MRSA screen (17.9)
Vancomycin (5.1)
Clindamycin (5.1)
Gram-negative (12.8)
Other (10.2)
Lengthening IV cephalosporin
(74.4)
IV vancomycin vs. cephalosporin
based on MRSA screen (15.4)
IV vancomycin (2.6)
Clindamycin (5.1)
Gram-negative (2.6)
Skin preparation
Insertion Chloraprep

(61.5)
Alcohol (38.5)
Betadine (23.1)
Duraprep
 (23.1)
Other (15.4)
Lengthening Chloraprep

(60.5)
Alcohol (36.8)
Betadine (23.7)
Duraprep
 (23.7)
Other (15.8)
Wound irrigation
Insertion Saline (74.4) Dilute betadine (17.9)
Bacitracin (15.4)
Other (7.7)
Lengthening Saline (84.2) Dilute betadine (13.2)
Bacitracin (7.9)
Other (7.9)
Topical antibiotics
Insertion Vancomycin (41) None (48)
Lengthening n/a
Dressing
Insertion Impervious seal
dressing (59)
Nonadherent dressing (28.2)
Standard seal tape (20.5)
Padding (25.6)
Other (25.6)
Lengthening n/a
Duration postoperative antibiotics
Insertion IV antibiotics
\24 h (64.1)
IV antibiotic[24 h (33.3)
Only a single preoperative dose (2.6)
Lengthening IV antibiotics
\24 h (47.4)
None (47)
IV antibiotic[24 h (2.6)
Oral antibiotics[24 h (2.6)
Certain questions allowed for choosing more than one selection so the
total percentage for each question does not equal 100 %
Chloraprep
 chlorhexidine gluconate, duraprep
 iodine povacrylex and
isopropyl alcohol, betadine povidone iodine
Table 2 Summary of survey results to questions asked including
most common and other methods used
Intervention Percentage used
Chlorhexidine baths
Insertion 46.1
Lengthening 41
Preoperative nutrition labs
Insertion 42.5
Lengthening 5
Preoperative MRSA swab
Insertion 30.8
Lengthening n/a
Drains
Insertion 41.1
Lengthening 2.6
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123use saline as an intraoperative irrigant while 7.9 % use
bacitracin, 13.2 % use dilute betadine, and 7.9 % respon-
ded ‘‘other.’’ Only 2.6 % of surveyed surgeons use drains
for lengthenings.
Postoperative infection
When asked how they would treat a superﬁcial infection,
43.6 % of surgeons treat superﬁcial infection with antibi-
otics only while 35.9 % treat with operative incision and
drainage (Fig. 2).
Discussion
The current study demonstrates that there is signiﬁcant
variability in practice regarding infection prevention mea-
sures in the growing spine population. This survey was
conducted amongst active members of two research groups
that work together frequently, are experienced with growth
friendly procedures, and are heavily invested in improving
the care of these children. Despite this group’s relative
familiarity of the current literature and treatment trends,
there was a signiﬁcant divergence of opinions on multiple
questions. Given the experience of the surgeons surveyed,
one might postulate that using the physicians surveyed in
these groups may actually underestimate the true vari-
ability in practice.
Patients with EOS encompass a diverse population and
include multiple diagnoses (idiopathic, congenital, neuro-
muscular, syndromic). Therefore, it is probably unreason-
able to suggest that a uniform blanket approach can be
applied to this population. Given the cost of an infection to
both the family and healthcare, understanding processes
that can reduce the risk of an infection is important. A
recent study (unpublished data) and several other published
studies have demonstrated a risk of infection in this pop-
ulation of up to 25 % [2–4]. Given the high incidence of
infection associated with these growth friendly procedures,
any measure that reduces this risk will have substantial
clinical importance.
Variability in medical practice is common, and most
studies suggest that efforts which reduce variability and
encourage adoption of best practice can have a positive
impact on both clinical outcome and healthcare cost [10–
12]. The orthopaedic literature, and speciﬁcally literature
related to preventing spinal infection, is largely comprised
of retrospective case series and expert opinion, rather than
true randomized clinical trials (RCTs) [13]. There are
considerable barriers to completing well-designed clinical
trials in orthopaedics; however, such studies are required to
improve our clinical processes [13]. With a lack of avail-
able good evidence, surgeons are faced with a difﬁcult
challenge to adopt best practices based on personal
experience.
While there is literature to suggest that measures such as
preoperative MRSA screening [14–16], chlorhexidine skin
preparation [17], use of dilute povidone iodine solution
prior to closure [18–21], and the use of gentamycin or
vancomycin in the bone graft after spinal fusion [22–27]
may reduce infection in some patients, it is not clear that
these studies can be generalized outside of the populations
studied. While the presence of this literature encourages
some to adapt these practices to the growing spine popu-
lation, it is not obvious that these interventions will have
similar outcomes in a much different patient population. It
is not surprising, given the diversity of the growing spinal
deformity population, and the lack of available evidence
that there is such variability in practice. While unreason-
able to expect that all variability can be eliminated, we can
postulate from other studies that any measures which
reduce variability and lead to standardized processes may
have a positive impact on this population.
While many factors such as skin preparation and wound
irrigation are similar between the two lengthening and
insertion groups, it should be noted that there are some key
differences with regard to infection prevention strategies
for a lengthening procedure. This is likely due to several
factors such as shorter operative time and smaller incisions,
Fig. 1 Graphical depiction of variability in skin preparation prior to
surgery amongst surgeons surveyed
Fig. 2 Variable approach of surgeons toward a superﬁcial infection
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123and that it is often a soft tissue procedure and does not
involve direct contact with the bone. This likely explains
the less frequent use of drains and intraoperative antibiot-
ics, as well as different strategies with regard to postop-
erative prophylaxis.
Often the best we can do is to collect the available
information and to synthesize it in a systemic manner. This
process requires identifying current practice and comparing
it to the available literature. Once this is done, the infor-
mation can be used to try to create best practice guidelines,
and to serve as a platform for designing prospective clinical
studies. This process has recently been proven effective for
high-risk spinal patients [7–9], and therefore this study
represents the ﬁrst step to adopting similar methodology to
the growing spine population. However, the individual
surgeon may use these results and choose methods in
which there is a majority opinion. While the majority
opinion may not be data driven, it offers opportunities to
reduce variability within one’s individual and institutional
process.
In addition to initiating a discussion that can be used to
develop best practice guidelines, this study can also be
used to design studies moving forward. For example, there
were a number of study questions identiﬁed in the current
study where there is sufﬁcient equipoise to design clinical
trials. Questions with a fairly diverse/even distribution of
answers in this study included the use of drains in insertion
procedures, using perioperative IV vancomycin or gram
negative coverage, postoperative antibiotic duration after
insertions and lengthenings, preoperative skin preparation,
antibiotic use in bone graft, preoperative MRSA screening,
and preoperative chlorhexidine baths.
There are several limitations to the current study. While
the response rate was fairly high, the physicians surveyed
represent a somewhat homogeneous, experienced popula-
tion in that they have a speciﬁc research interest in this
population. Further, while we may postulate that variability
is bad for clinical care, the effect of variability in infection
prevention after surgery for EOS is unproven. Finally, this
study is essentially expert opinion, and only represents a
summary of surgeon opinions. The purpose here is to dem-
onstratethecurrentvariabilityofpractice,andisnotmeantto
suggest which treatments may or may not reduce infection
rates, as that is outside the scope of the current paper.
Conclusion
There is signiﬁcant variability of current practices of sur-
geons who perform surgery for EOS. Variability in medical
practice is probably not ideal, and measures which can
reduce this variability may have a positive impact on both
patient outcomes and health care efﬁciency. Identifying
majority opinion practices within this study can be a
starting point to reducing individual and institutional var-
iability. Further, this study is the ﬁrst step in identifying
best practices as well as potential topics for multicenter
collaborative research.
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